TALAZOPARIB 0.1MG / 0.25MG

🧪 Composition

• Active Ingredient: Talazoparib
• Dosage Form: Oral Capsule
• Strength: 0.1 mg

✅ Uses

• Used for the treatment of germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer in eligible adults.
• May be prescribed for selected patients with BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in accordance with approved indications and clinical guidelines.
• Helps slow the growth and spread of cancer cells.
• Used as part of a personalized treatment plan based on genetic testing.

💉 Dosage

Take Talazoparib 0.1 mg exactly as prescribed by your healthcare provider. The dosage depends on the patient’s medical condition, kidney function, previous treatments, and response to therapy. Swallow the capsule whole with water, with or without food. Do not change the dose or discontinue treatment without medical advice.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular monitoring of blood cell counts and kidney function may be required during treatment.
• Inform your doctor about any history of kidney disease, anemia, or other blood disorders before starting therapy.
• Report symptoms such as unusual bruising or bleeding, persistent fatigue, fever, or shortness of breath immediately.

📦 Storage

Store the capsules at room temperature in a cool, dry place away from heat, moisture, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Talazoparib 0.1 mg is an advanced targeted therapy for eligible patients with BRCA-mutated cancers, including selected cases of breast and prostate cancer. When used under specialist supervision and guided by genetic testing, it helps slow disease progression and supports improved treatment outcomes. Always follow your healthcare provider’s recommendations for safe and effective use.